NYSE - Nasdaq Real Time Price USD

Enhabit, Inc. (EHAB)

9.48

+1.28

+(15.61%)

As of 11:59:31 AM EDT. Market Open.

Enhabit (EHAB) Q1 Earnings Top Estimates

Enhabit (EHAB) delivered earnings and revenue surprises of 42.86% and 2.56%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 16 hours ago

EHAB
+15.61%
Enhabit: Q1 Earnings Snapshot

DALLAS (AP) — Enhabit Inc. EHAB) on Wednesday reported earnings of $17.8 million in its first quarter. The Dallas-based company said it had profit of 35 cents per share.

Associated Press Finance 17 hours ago

EHAB
+15.61%
Enhabit Reports First Quarter 2025 Financial Results

DALLAS, May 07, 2025--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025.

Business Wire 19 hours ago

EHAB
+15.61%
Insider Stock Buying Reaches US$526.5k On Enhabit

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...

Simply Wall St. 14 days ago

EHAB
+15.61%
Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call

DALLAS, April 17, 2025--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

Business Wire 20 days ago

EHAB
+15.61%
Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?

Here is how Enhabit (EHAB) and Doximity (DOCS) have performed compared to their sector so far this year.

Zacks 28 days ago

EHAB
+15.61%

DOCS
Danaher Gains From Strength in the Diagnostics Unit Amid Headwinds

DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies. Softness in Life Sciences and Biotechnology units remains a concern.

Zacks last month

DHR

EHAB
+15.61%
Why Fast-paced Mover Enhabit (EHAB) Is a Great Choice for Value Investors

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Enhabit (EHAB) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Zacks last month

EHAB
+15.61%
Is Bayer (BAYRY) Stock Outpacing Its Medical Peers This Year?

Here is how Bayer Aktiengesellschaft (BAYRY) and Enhabit (EHAB) have performed compared to their sector so far this year.

Zacks last month

BAYN.DE

EHAB
+15.61%
Surging Earnings Estimates Signal Upside for Enhabit (EHAB) Stock

Enhabit (EHAB) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks last month

EHAB
+15.61%
Enhabit Home Health & Hospice Achieves Level 2 Recognition as an Age-Friendly Health System — Committed to Care Excellence

DALLAS, March 11, 2025--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that it has achieved Level 2 recognition as an Age-Friendly Health System – Committed to Care Excellence by the Institute for Healthcare Improvement (IHI). This prestigious recognition honors Enhabit’s dedication to providing high-quality, evidence-based care to older adults, ensuring their unique needs and preferences are consistently met.

Business Wire last month

EHAB
+15.61%
Here's Why You Should Avoid Betting on Danaher Stock Right Now

Persistent softness in the Life Sciences segment weighs on DHR's performance. An increase in operating expenses is an added concern.

Zacks last month

DHR

EHAB
+15.61%
Enhabit Inc (EHAB) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Enhabit Inc (EHAB) reports mixed results with strong hospice growth and strategic expansions, despite revenue challenges and operational adjustments.

GuruFocus.com 2 months ago

EHAB
+15.61%
Q4 2024 Enhabit Inc Earnings Call

Q4 2024 Enhabit Inc Earnings Call

Thomson Reuters StreetEvents 2 months ago

EHAB
+15.61%
Enhabit (EHAB) Q4 Earnings and Revenues Miss Estimates

Enhabit (EHAB) delivered earnings and revenue surprises of -20% and 0.37%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

EHAB
+15.61%
Enhabit: Q4 Earnings Snapshot

DALLAS (AP) — Enhabit Inc. EHAB) on Wednesday reported a loss of $46 million in its fourth quarter. On a per-share basis, the Dallas-based company said it had a loss of 92 cents.

Associated Press Finance 2 months ago

EHAB
+15.61%
Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance

DALLAS, March 05, 2025--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024.

Business Wire 2 months ago

EHAB
+15.61%
Viatris (VTRS) Q4 Earnings and Revenues Lag Estimates

Viatris (VTRS) delivered earnings and revenue surprises of -5.26% and 2.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

VTRS

EHAB
+15.61%
Enhabit Home Health & Hospice to Nominate Stephan Rodgers to Board of Directors

DALLAS, February 25, 2025--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced its board of directors will nominate Stephan Rodgers to stand for election as a director of the company at Enhabit’s 2025 annual meeting of stockholders.

Business Wire 2 months ago

EHAB
+15.61%
Enhabit (EHAB) Is Attractively Priced Despite Fast-paced Momentum

Enhabit (EHAB) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Zacks 2 months ago

EHAB
+15.61%

Performance Overview

Return	EHAB	S&P 500 (^GSPC)
YTD	+21.38%	-3.00%
1-Year	-2.27%	+9.98%
3-Year	-62.08%	+38.36%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Enhabit, Inc. (EHAB)

Enhabit (EHAB) Q1 Earnings Top Estimates

Enhabit: Q1 Earnings Snapshot

Enhabit Reports First Quarter 2025 Financial Results

Insider Stock Buying Reaches US$526.5k On Enhabit

Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call

Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?

Danaher Gains From Strength in the Diagnostics Unit Amid Headwinds

Why Fast-paced Mover Enhabit (EHAB) Is a Great Choice for Value Investors

Is Bayer (BAYRY) Stock Outpacing Its Medical Peers This Year?

Surging Earnings Estimates Signal Upside for Enhabit (EHAB) Stock

Enhabit Home Health & Hospice Achieves Level 2 Recognition as an Age-Friendly Health System — Committed to Care Excellence

Here's Why You Should Avoid Betting on Danaher Stock Right Now

Enhabit Inc (EHAB) Q4 2024 Earnings Call Highlights: Navigating Growth Amidst Challenges

Q4 2024 Enhabit Inc Earnings Call

Enhabit (EHAB) Q4 Earnings and Revenues Miss Estimates

Enhabit: Q4 Earnings Snapshot

Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance

Viatris (VTRS) Q4 Earnings and Revenues Lag Estimates

Enhabit Home Health & Hospice to Nominate Stephan Rodgers to Board of Directors

Enhabit (EHAB) Is Attractively Priced Despite Fast-paced Momentum

Performance Overview